Modified systemic immune-inflammatory index, modified systemic inflammatory response index and hemoglobin-albumin-lymphocyte-platelet score may serve as markers for evaluating the efficacy of neoadjuvant therapy in breast cancer patients
Elevated mSII, mSIRI, and low HALP score were associated with the effectiveness of NAT in breast cancer. mSII, mSIRI, and HALP score may serve as valuable predictive indicators for the effectiveness of neoadjuvant therapy in breast cancer.
Authors
- Qiao Wang (ORCID: https://orcid.org/0000-0002-8854-4744)
- Rongkun Zhu
- Y Gan
- Jinyuan Li
- Xiaobin Meng
Institutions
- Meizhou City People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-13
- DOI
- https://doi.org/10.3389/fonc.2026.1746164
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00